✦ LIBER ✦

Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma

✍ Scribed by Sally J. DeNardo; Linda A. Kroger; Kathleen R. Lamborn; Laird A. Miers; Robert T. O'Donnell; David L. Kukis; Carol M. Richman; Gerald L. DeNardo

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 186 KB
Volume: 80
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2583::aid-cncr34>3.0.co;2-6

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

The beneficial effects of radioimmunotherapy (RIT) may result from

📜 SIMILAR VOLUMES

Management of inflammatory carcinoma of

Management of inflammatory carcinoma of breast with combined modality approach—an update

✍ Aman U. Buzdar; Eleanor D. Montague; Jerry L. Barker; Gabriel N. Hortobagyi; Geo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

Thirty-two patients with inflammatory breast cancer were treated with a combined modality approach consisting of combination chemotherapy with fluorouracil, doxorubicin hydrochloride, and cyclophosphamide, followed by radiation therapy. The disease-free interval and survival of this group were compa

Surgery as part of a combined modality a

Surgery as part of a combined modality approach for inflammatory breast carcinoma

✍ Peter Schäfer; Pierre Alberto; Michel Forni; Dragan Obradovic; Gudrun Pipard; Fe 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 1 views

Sensorineural hearing loss in combined m

Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma

✍ William C. Chen; Andrew Jackson; Amy S. Budnick; David G. Pfister; Dennis H. Kra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Combined therapy in carcinomas of the fe

Combined therapy in carcinomas of the female breast

✍ Dr. V. Shanta; S. Krishnamurthi 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

## Abstract Of 606 female breast cancers treated, 364 of them in stage I, II, and III, only 7 cases were in stage I. All stage II and III cases in good general condition received radical preoperative irradiation to the entire breast volume and the regional lymphatic areas over a period of 4 wk, fol

Toxicity and efficacy of combined radioi

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma

✍ Pierre-Yves Salaun; Caroline Bodet-Milin; Eric Frampas; Aurore Oudoux; Catherine 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract ## BACKGROUND: Significant antitumor effects were previously observed with radioimmunotherapy (RIT) using an anti‐carcinoembryonic antigen (CEA) monoclonal antibody (F6) labeled with iodine‐131 in medullary thyroid cancer (MTC)‐bearing nude mice. Nevertheless, no complete response was

Peripheral blood stem cell mobilization

Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma

✍ Carol M. Richman; Tina C. Schuermann; Theodore Wun; Rajiv Malik; Robert T. O'Don 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. In clinical trials of radiolabeled monoclonal antibodies targeting